ES3066019T3 - Btk inhibitor for use in the treatment of iga nephropathy or purpura nephritis - Google Patents
Btk inhibitor for use in the treatment of iga nephropathy or purpura nephritisInfo
- Publication number
- ES3066019T3 ES3066019T3 ES20903242T ES20903242T ES3066019T3 ES 3066019 T3 ES3066019 T3 ES 3066019T3 ES 20903242 T ES20903242 T ES 20903242T ES 20903242 T ES20903242 T ES 20903242T ES 3066019 T3 ES3066019 T3 ES 3066019T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- btk inhibitor
- iga nephropathy
- purpura nephritis
- purpura
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019229171 | 2019-12-19 | ||
| PCT/JP2020/047370 WO2021125313A1 (ja) | 2019-12-19 | 2020-12-18 | 縮合ピリミジン化合物を有効成分とする治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3066019T3 true ES3066019T3 (en) | 2026-05-11 |
Family
ID=76476851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES20903242T Active ES3066019T3 (en) | 2019-12-19 | 2020-12-18 | Btk inhibitor for use in the treatment of iga nephropathy or purpura nephritis |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230064254A1 (es) |
| EP (1) | EP4079306B1 (es) |
| JP (1) | JP7304968B2 (es) |
| CN (1) | CN114828856B (es) |
| DK (1) | DK4079306T3 (es) |
| ES (1) | ES3066019T3 (es) |
| FI (1) | FI4079306T3 (es) |
| PL (1) | PL4079306T3 (es) |
| PT (1) | PT4079306T (es) |
| TW (1) | TWI895316B (es) |
| WO (1) | WO2021125313A1 (es) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2947086B1 (en) * | 2013-08-12 | 2018-01-03 | Taiho Pharmaceutical Co., Ltd. | Novel fused pyrimidine compound or salt thereof |
| WO2015170266A1 (en) * | 2014-05-07 | 2015-11-12 | Lupin Limited | Substituted pyrimidine compounds as btk inhibitors |
| JP6619361B2 (ja) * | 2014-11-03 | 2019-12-11 | シャウ−ロン リー | ＩｇＡ腎症を治療するためのジンセノサイドＭ１の使用 |
| DK3120852T3 (da) * | 2015-01-30 | 2019-07-29 | Taiho Pharmaceutical Co Ltd | Præventivt og/eller terapeutisk middel til immunsygdomme |
| WO2016121954A1 (ja) * | 2015-01-30 | 2016-08-04 | 大鵬薬品工業株式会社 | 縮合ピリミジン化合物の新規な塩及びその結晶 |
| EP3337805A4 (en) * | 2015-05-27 | 2019-04-03 | Pharmascience Inc. | INHIBITORS OF THE TEC KINASE ENZYM FAMILY |
| BR112020003737A2 (pt) * | 2017-08-31 | 2020-09-01 | Novartis Ag | usos de derivados de piperidinil-indol |
-
2020
- 2020-12-18 WO PCT/JP2020/047370 patent/WO2021125313A1/ja not_active Ceased
- 2020-12-18 DK DK20903242.4T patent/DK4079306T3/da active
- 2020-12-18 PL PL20903242.4T patent/PL4079306T3/pl unknown
- 2020-12-18 US US17/786,504 patent/US20230064254A1/en active Pending
- 2020-12-18 FI FIEP20903242.4T patent/FI4079306T3/fi active
- 2020-12-18 PT PT209032424T patent/PT4079306T/pt unknown
- 2020-12-18 EP EP20903242.4A patent/EP4079306B1/en active Active
- 2020-12-18 TW TW109144947A patent/TWI895316B/zh active
- 2020-12-18 CN CN202080087359.0A patent/CN114828856B/zh active Active
- 2020-12-18 JP JP2021565673A patent/JP7304968B2/ja active Active
- 2020-12-18 ES ES20903242T patent/ES3066019T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4079306A1 (en) | 2022-10-26 |
| TWI895316B (zh) | 2025-09-01 |
| WO2021125313A1 (ja) | 2021-06-24 |
| JP7304968B2 (ja) | 2023-07-07 |
| FI4079306T3 (fi) | 2026-03-26 |
| PT4079306T (pt) | 2026-03-13 |
| CN114828856B (zh) | 2024-11-05 |
| TW202135817A (zh) | 2021-10-01 |
| JPWO2021125313A1 (es) | 2021-06-24 |
| EP4079306B1 (en) | 2026-02-18 |
| EP4079306A4 (en) | 2024-01-10 |
| US20230064254A1 (en) | 2023-03-02 |
| DK4079306T3 (da) | 2026-03-23 |
| CN114828856A (zh) | 2022-07-29 |
| PL4079306T3 (pl) | 2026-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288231A (en) | An inhibitor of jak1/2 or a pharmaceutical salt derived from it and an inhibitor of pi3k or a pharmaceutical salt derived from it, for use in the treatment of myelofibroblasts. | |
| SG10201913331VA (en) | Combinations of lsd1 inhibitors for use in the treatment of solid tumors | |
| SI3435996T1 (sl) | Elafibranor za uporabo pri zdravljenju primarnega žolčnega holangitisa | |
| IL279260A (en) | KDM1A inhibitors for the treatment of diseases | |
| PL4076652T3 (pl) | Farmaceutycznie dopuszczalna sól atrasentanu do zastosowania w sposobie leczenia nefropatii iga | |
| PL3481846T3 (pl) | 11-podstawione 24-hydroksysterole do stosowania w leczeniu stanów związanych z NMDA | |
| PL3302519T3 (pl) | Inhibitor dopełniacza ornithodoros moubata do zastosowania w leczeniu ostrej choroby przeszczep przeciwko gospodarzowi | |
| ES2856150T5 (en) | Use of an inverse transcriptase inhibitor for the treatment and prevention of degenerative diseases | |
| HUE043496T2 (hu) | 2-aminotiazol származék hólyag/húgyúti betegségek megelõzésében vagy kezelésében történõ alkalmazásra | |
| SI3093022T1 (sl) | GATA-3 inhibitorji za uporabo pri zdravljenju astme, ki jo povzroča TH2 | |
| IL283031A (en) | And will grow to treat the symptoms of overactivity in the gland | |
| PL3197556T3 (pl) | KOMPOZYCJA DO ZAPOBIEGANIA l/LUB LECZENIA OBJAWÓW ALERGII | |
| ZA201708608B (en) | Il-8 inhibitors for use in the treatment of certain urological disorders | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| PL4079306T3 (pl) | Inhibitor btk do stosowania w leczeniu nefropatii iga lub plamicowego zapalenia nerek | |
| IL276697A (en) | 3 Beta-(4-methoxybenzyloxy)paragan-5-en-20-one for use in the treatment of cannabinoid-related disorders | |
| PT3765012T (pt) | Inibidores de dgat1 para utilização no tratamento de obstipação | |
| PT3191112T (pt) | Compostos de dipeptidilcetoamida e sua utilização para o tratamento e/ou prevenção da acumulação de gordura | |
| HUE070898T2 (hu) | Kombináció a gyomor-reflux nyelõcsövön kívüli tüneteinek kezelésében történõ alkalmazásra | |
| PL3436009T3 (pl) | Ujemne modulatory allosteryczne mglur5 do użycia w leczeniu rozwiniętych uszkodzeń mózgu | |
| IL290818A (en) | Use of an mdm2 inhibitor to treat myelofibrosis | |
| IL277902A (en) | Nazartinib for use in the treatment of CNS metastasis | |
| LT3413894T (lt) | P13k aktyvumo arba funkcijos inhibitorių panaudojimas pirminio sjögren'o sindromo gydymui | |
| HK40000038A (en) | Wnt inhibitors for use in the treatment of fibrosis |